COSTS-CONSEQUENCES ANALYSIS OF CEFTAROLINE FOSAMIL FOR THE TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM

被引：0
|
作者：
Salgado, De Santana C. [1 ]
Holanda, P. [2 ]
Senna, T. [2 ]
Carmo, L. [2 ]
Alexandre, R. F. [2 ]
机构：
[1] Pfizer, Santos, SP, Brazil
[2] Pfizer, Sao Paulo, Brazil
来源：
VALUE IN HEALTH | 2021年 / 24卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PIN23
引用
收藏
页码：S109 / S109
页数：1
相关论文
共 50 条
  • [21] Ceftaroline Fosamil: A Review of its Use in the Treatment of Complicated Skin and Soft Tissue Infections and Community-Acquired Pneumonia
    Frampton, James E.
    DRUGS, 2013, 73 (10) : 1067 - 1094
  • [22] Ceftaroline fosamil for treatment of community-acquired pneumonia: findings from FOCUS 1 and 2 and potential role in therapy
    DiMondi, V. Paul
    Drew, Richard H.
    Chen, Luke F.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2011, 9 (08) : 567 - 572
  • [23] EFFICACY OF CEFTAROLINE FOSAMIL AND OTHER INTRAVENOUS ANTIBIOTICS IN THE TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA (CAP): A NETWORK META-ANALYSIS (NMA)
    Medic, G.
    Karabis, A.
    Borrill, J.
    Worrall, J.
    Bergman, G.
    VALUE IN HEALTH, 2012, 15 (07) : A385 - A385
  • [24] Ceftaroline fosamil for community-acquired bacterial pneumonia and acute bacterial skin and skin structure infection
    Casapao, Anthony M.
    Steed, Molly E.
    Levine, Donald P.
    Rybak, Michael J.
    EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (08) : 1177 - 1186
  • [25] Pharmacokinetic-Pharmacodynamic Analyses for Efficacy of Ceftaroline Fosamil in Patients with Community-Acquired Bacterial Pneumonia
    Bhavnani, Sujata M.
    Hammel, Jeffrey P.
    Van Wart, Scott A.
    Rubino, Christopher M.
    Reynolds, Daniel K.
    Forrest, Alan
    Khariton, Tatiana
    Friedland, H. David
    Riccobene, Todd A.
    Ambrose, Paul G.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (12) : 6348 - 6350
  • [26] Capture: Ceftaroline Fosamil For The Treatment Of Community Acquired Bacterial Pneumonia (cabp): Year 1
    Udeani, G.
    Jandourek, A.
    Li, Y.
    Friedland, H. D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [27] Ceftaroline fosamil treatment patterns and outcomes in adults with community-acquired pneumonia: a real-world multinational, retrospective study
    Soriano, Alex
    Bassetti, Matteo
    Gogos, Charalambos
    Ferry, Tristan
    de Pablo, Raul
    Ansari, Wajeeha
    Kantecki, Michal
    Schweikert, Bernd
    Luna, Gustavo
    Blasi, Francesco
    JAC-ANTIMICROBIAL RESISTANCE, 2024, 6 (03):
  • [28] Ceftaroline fosamil versus ceftriaxone for the treatment of community-acquired pneumonia: individual patient data meta-analysis of randomized controlled trials
    Taboada, Maria
    Melnick, David
    Iaconis, Joseph P.
    Sun, Fang
    Zhong, Nan Shan
    File, Thomas M.
    Llorens, Lily
    Friedland, H. David
    Wilson, David
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (04) : 862 - 870
  • [29] Ceftaroline fosamil for treating skin and skin structure infections or community-acquired pneumonia in patients with renal insufficiency
    Maggiore, Christy
    Pasquale, Timothy
    Cole, Phillip
    Friedland, H. David
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2015, 8 (01) : 141 - 153
  • [30] Assessment of ceftaroline fosamil in the treatment of community-acquired bacterial pneumonia due to Streptococcus pneumoniae: insights from two randomized trials
    Shorr, Andrew F.
    Kollef, Mann
    Eckburg, Paul B.
    Llorens, Lily
    Friedland, H. David
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2013, 75 (03) : 298 - 303
12345